Profit Jumps For Zimmer Biomet
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowWarsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) is reporting third quarter net income of $162 million, up from $98.8 million during the same period last year. Chief Executive Officer Bryan Hanson says the earnings reflect the company’s sustained progress in a number of areas.
The medical device manufacturer says net sales for the quarter topped $1.8 billion, a 1.3 percent increase over the third quarter of 2017. Hanson said he is pleased with the results.
"Although our sales results clearly benefited from less challenging sales comparisons, as well as the timing of certain tenders and capital sales, our organic growth continued to signal that we are turning the business around consistent with our expectations," Hanson said in a news release. "Looking to the balance of the year, we will continue to focus on priorities to improve the consistency of our results and drive sustained value creation. These include important new innovations that are expanding our comprehensive portfolio, advancing standards of care and creating new opportunities for our salesforce to deliver growth."
You can connect to the full third quarter earnings report by clicking here.